James G. Binch Sells 747 Shares of Exactech, Inc. (EXAC) Stock

Exactech, Inc. (NASDAQ:EXAC) Director James G. Binch sold 747 shares of the business’s stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $28.40, for a total transaction of $21,214.80. Following the transaction, the director now directly owns 3,554 shares of the company’s stock, valued at $100,933.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Shares of Exactech, Inc. (NASDAQ EXAC) opened at 29.95 on Friday. The company has a 50 day moving average of $29.41 and a 200-day moving average of $28.11. The company has a market capitalization of $429.72 million, a P/E ratio of 575.96 and a beta of 1.02. Exactech, Inc. has a 12-month low of $22.20 and a 12-month high of $31.90.

Exactech (NASDAQ:EXAC) last posted its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $0.33 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.33. The company had revenue of $67.30 million for the quarter, compared to the consensus estimate of $67.75 million. Exactech had a net margin of 0.30% and a return on equity of 7.39%. The firm’s revenue was up 1.8% compared to the same quarter last year. During the same period last year, the company earned $0.31 earnings per share. On average, equities analysts anticipate that Exactech, Inc. will post $1.29 EPS for the current fiscal year.

WARNING: “James G. Binch Sells 747 Shares of Exactech, Inc. (EXAC) Stock” was published by BNB Daily and is the property of of BNB Daily. If you are reading this piece on another site, it was stolen and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.baseball-news-blog.com/2017/08/19/insider-selling-exactech-inc-exac-director-sells-747-shares-of-stock-updated.html.

A number of institutional investors have recently modified their holdings of EXAC. Kirr Marbach & Co. LLC IN increased its position in shares of Exactech by 1.2% in the first quarter. Kirr Marbach & Co. LLC IN now owns 10,760 shares of the medical equipment provider’s stock worth $271,000 after buying an additional 125 shares during the last quarter. The Manufacturers Life Insurance Company increased its position in shares of Exactech by 3.2% in the second quarter. The Manufacturers Life Insurance Company now owns 9,323 shares of the medical equipment provider’s stock worth $278,000 after buying an additional 289 shares during the last quarter. American International Group Inc. increased its position in shares of Exactech by 7.1% in the first quarter. American International Group Inc. now owns 6,423 shares of the medical equipment provider’s stock worth $162,000 after buying an additional 424 shares during the last quarter. ClariVest Asset Management LLC increased its position in shares of Exactech by 5.4% in the first quarter. ClariVest Asset Management LLC now owns 10,908 shares of the medical equipment provider’s stock worth $275,000 after buying an additional 554 shares during the last quarter. Finally, Teachers Advisors LLC increased its position in shares of Exactech by 2.7% in the second quarter. Teachers Advisors LLC now owns 21,549 shares of the medical equipment provider’s stock worth $642,000 after buying an additional 568 shares during the last quarter. Institutional investors and hedge funds own 64.05% of the company’s stock.

A number of brokerages have recently weighed in on EXAC. BidaskClub lowered shares of Exactech from a “hold” rating to a “sell” rating in a research note on Monday, July 31st. Zacks Investment Research raised shares of Exactech from a “sell” rating to a “hold” rating in a research note on Tuesday, April 25th. Gabelli reaffirmed a “buy” rating on shares of Exactech in a research note on Monday, July 31st. Finally, TheStreet raised shares of Exactech from a “c+” rating to a “b” rating in a research note on Tuesday, April 25th.

About Exactech

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Insider Buying and Selling by Quarter for Exactech (NASDAQ:EXAC)

Receive News & Ratings for Exactech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply